Boehringer Ingelheim Pharmaceuticals Inc. et al v. Granules India Limited et al
| Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG |
| Granules India Limited and Granules Pharmaceuticals, Inc. |
| 1:2025cv00663 |
| May 29, 2025 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 2, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2; 10,258,637 B2; 11,090,323 B2; 11,833,166 B2. (Attachments: #1 D.I. 12 Consent Judgment) (mws) |
| Filing 12 CONSENT JUDGMENT. Party Boehringer Ingelheim Corporation terminated. (CASE CLOSED). Signed by Judge Colm F. Connolly on 9/2/2025. (mws) |
| Filing 11 PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Filing 10 STIPULATION TO EXTEND TIME for Defendants to file an answer to the Complaint (D.I. 1) to September 2, 2025 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME for Defendants to file an answer to the Complaint (D.I. 1) to September 2, 2025, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Reset Answer Deadlines: Granules India Limited answer due 9/2/2025; Granules Pharmaceuticals, Inc. answer due 9/2/2025. Ordered by Judge Colm F. Connolly on 8/18/2025. (kmd)
|
| Filing 9 WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG: For Granules Pharmaceuticals, Inc. waiver sent on 6/17/2025, answer due 8/18/2025. (Dellinger, Megan) |
| Filing 8 WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG: For Granules India Limited waiver sent on 6/17/2025, answer due 8/18/2025. (Dellinger, Megan) |
| Filing 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb) |
| Filing 6 Summons Issued as to Granules India Limited on 5/30/2025; Granules Pharmaceuticals, Inc. on 5/30/2025. (Attachments: #1 Summons Issued)(scs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (scs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2; 10,258,637 B2; 11,090,323 B2; 11,833,166 B2. (scs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about April 17, 2025. Date of Expiration of Patent: *see form for details.Thirty Month Stay Deadline: 10/17/2027. (scs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
| Filing 1 COMPLAINT against Granules India Limited, Granules Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4698713) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG. (Attachments: #1 Exhibits A-D, #2 Civil Cover Sheet)(scs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
